Skip to main content
Equibles
TDOC logo

TDOC · Teladoc Health, Inc. · Analyst Estimates

Track TDOC — free

Use TDOC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TDOC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$6.45 +0.21 (+3.37%) At close · Oct 27 Earnings today Q2 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Customer concentration — key customers 31% of revenue

Key customers — 31% of revenue (the three months ended March 31, 2026)

“Revenue from the five largest Clients accounted for 31% of total Integrated Care segment revenue for each of the three months ended March 31, 2026 and 2025.”
View the 10-Q filed Apr 30, 2026
Market Cap
$1.16B
Shares
181.68M
Volume · Oct 27 3.98M Avg daily vol (3M) 4.19M

Analyst Estimates

Compare analyst forecasts for Teladoc Health, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-27 21:54 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.99
-0.79
-0.66
3
-0.79
-0.78
-0.78
-0.79
2
2
1
1
Revenue
USD
Publication date not stated
2.36B
2.42B
2.52B
21
 — — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-1.02
-0.72
-0.55
3
-0.72
-0.79
-0.79
-0.65
1
1
1
1
Revenue
USD
Publication date not stated
2.21B
2.40B
2.57B
21
 — — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.23
-0.19
-0.15
3
-0.19
-0.21
-0.21
-0.15
2
2
0
0
Revenue
USD
Publication date not stated
571.80M
590.09M
628.00M
19
 — — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.19
-0.087
-0.03
3
-0.087
-0.12
-0.12
-0.11
1
1
1
1
Revenue
USD
Publication date not stated
571.58M
599.41M
652.80M
19
 — — — — — — — —
Key facts CIK 1477449 CUSIP 87918A105 13F (30d) 70 filings 67 filers Visit website Investor relations